[go: up one dir, main page]

WO2009101185A3 - A polymorphic form of a pyrazino [2, 3-h] [3] benzazepine derivative - Google Patents

A polymorphic form of a pyrazino [2, 3-h] [3] benzazepine derivative Download PDF

Info

Publication number
WO2009101185A3
WO2009101185A3 PCT/EP2009/051727 EP2009051727W WO2009101185A3 WO 2009101185 A3 WO2009101185 A3 WO 2009101185A3 EP 2009051727 W EP2009051727 W EP 2009051727W WO 2009101185 A3 WO2009101185 A3 WO 2009101185A3
Authority
WO
WIPO (PCT)
Prior art keywords
pyrazino
polymorphic form
benzazepine derivative
benzazepine
varenicline base
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2009/051727
Other languages
French (fr)
Other versions
WO2009101185A2 (en
Inventor
Stephen Benedict David Winter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medichem SA
Original Assignee
Medichem SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medichem SA filed Critical Medichem SA
Priority to EP09709821A priority Critical patent/EP2260037A2/en
Publication of WO2009101185A2 publication Critical patent/WO2009101185A2/en
Publication of WO2009101185A3 publication Critical patent/WO2009101185A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Addiction (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

The invention relates generally to a crystalline polymorphic form of 7, 8, 9, 10-tetrahydro-6, 10-methano-6H-pyrazino[2, 3-h][3] benzazepine, varenicline base, i.e. a hydrate of varenicline base, designated herein as Form II, and to a method for preparing and obtaining the same.
PCT/EP2009/051727 2008-02-15 2009-02-13 A NEW POLYMORPHIC FORM OF A PYRAZINO[2,3-h][3] BENZAZEPINE DERIVATIVE Ceased WO2009101185A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP09709821A EP2260037A2 (en) 2008-02-15 2009-02-13 A polymorphic form of a pyrazino [2,3-h] [3] benzazepine derivative

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6603208P 2008-02-15 2008-02-15
US61/066,032 2008-02-15

Publications (2)

Publication Number Publication Date
WO2009101185A2 WO2009101185A2 (en) 2009-08-20
WO2009101185A3 true WO2009101185A3 (en) 2009-12-03

Family

ID=40852121

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2009/051727 Ceased WO2009101185A2 (en) 2008-02-15 2009-02-13 A NEW POLYMORPHIC FORM OF A PYRAZINO[2,3-h][3] BENZAZEPINE DERIVATIVE

Country Status (2)

Country Link
EP (1) EP2260037A2 (en)
WO (1) WO2009101185A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11602537B2 (en) 2022-03-11 2023-03-14 Par Pharmaceutical, Inc. Varenicline compound and process of manufacture thereof
EP4241775A1 (en) 2022-03-11 2023-09-13 Par Pharmaceutical, Inc. Tablet comprising varenicline and process of preparation thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1157726A1 (en) * 2000-05-26 2001-11-28 Pfizer Products Inc. Reactive crystallization method to improve particle size
US6410550B1 (en) * 1997-12-31 2002-06-25 Pfizer Inc Aryl fused azapolycyclic compounds
US20030060624A1 (en) * 2001-04-20 2003-03-27 Singer Robert A. Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic componunds

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6410550B1 (en) * 1997-12-31 2002-06-25 Pfizer Inc Aryl fused azapolycyclic compounds
EP1157726A1 (en) * 2000-05-26 2001-11-28 Pfizer Products Inc. Reactive crystallization method to improve particle size
US20030060624A1 (en) * 2001-04-20 2003-03-27 Singer Robert A. Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic componunds

Also Published As

Publication number Publication date
WO2009101185A2 (en) 2009-08-20
EP2260037A2 (en) 2010-12-15

Similar Documents

Publication Publication Date Title
IL278119B (en) Substituted pyrazolo[1,5-a]pyrimidine compounds as trk kinase inhibitors
IL204720A0 (en) Imidazo [1, 2 - a] pyridine derivatives useful as alk inhibitors
PT2350075E (en) Substituted imidazo[1,2b]pyridazine compounds as trk kinase inhibitors
IL189276A0 (en) Novel crystalline form of a pyridazino [4,5-b] indole derivative
ZA201200982B (en) Substituted pyrazolo[1,5-a]pyrimidine compounds as trk kinase inhibitors
PL1904494T3 (en) Imidazo[1,2-a]pyridine compounds as vegf-r2 inhibitors
IL179406A0 (en) Tetrahydro-imidazo[1,5-a] pyridin derivatives as aldosterone synthase inhibitors
PL2124944T3 (en) Pyrazolo[3,4-b]pyridine derivatives as phosphodiesterase inhibitors
WO2010014883A3 (en) Azacitidine process and polymorphs
WO2010080242A3 (en) Uzm-27 family of crystalline aluminosilicate compositions, a method of preparing the compositions and methods of using the compositions
IL210074A (en) Process for the preparation of derivatives of pyrido[2,3-d]pyrimidine-7-yl-phenyl
WO2008068625A3 (en) Processes for preparing cinacalcet hydrochloride and polymorphic forms thereof
ZA200905832B (en) Crystalline forms of an 8-azabicyclo [3.2.1] octane compound
WO2008140646A3 (en) Process for the synthesis of cmhtp and intermediates thereof
WO2009101185A3 (en) A polymorphic form of a pyrazino [2, 3-h] [3] benzazepine derivative
WO2007081907A3 (en) Crystalline forms of dolasetron base and processes for preparation thereof
IL187441A0 (en) Derivatives of 6,7-dihydro-5h-imidazo[1,2-a] imidazole-3-sulfonic acid
IL206032A0 (en) Stable crystalline salt of (r)-3-fluorophenyl-3,4,5-trifluorobenzylcarbamic acid 1-azabiciyclo [2.2.2]oct-3-yl ester
IL202016A0 (en) Process for the preparation of dibenzo [b,d]azepin-6-one derivative
WO2009027766A3 (en) New crystalline solid forms of o-desvenlafaxine base
IL211221A0 (en) Process for preparing polymorph of 7-chloro-n,n,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4h-pyridazino [4,5-b] indole-1-acetamide
WO2010001408A3 (en) Novel polymorphic forms of gemifloxacin mesylate
PL386207A1 (en) Method of obtaining 3,6-di(2-chlorophenylo)-1,4-dihydro-1,2,4,5-tetrazine
WO2008039492A3 (en) Crystalline forms of valrubicin and processes for their preparation
PL2081934T3 (en) Process for the manufacture of a crystalline pyrazolo[1,5-a]pyrimidine compound

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09709821

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2009709821

Country of ref document: EP